News

WASHINGTON, D.C. – Today, Congressman Earl L. "Buddy Carter" (GA-01), Chairman of the Subcommittee on Health, led a hearing titled Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain. “Under the leadership of President Trump, we are bringing manufacturing back to America,” said Chairman Carter. “ Since the start of this year – the start of President Trump’s second term – Johnson & Johnson broke ground on a new $2 billion facility in North Carolina, Amgen announced a $900 million manufacturing expansion in Ohio, AbbVie committed $10 billion to invest in the United States, and Sanofi announced plans to invest at least $20 billion. And these are just a few examples; this is just the start.” Watch the full hearing here . Below are key excerpts from today’s hearing: Congressman Buddy Carter (GA-01): “If Congress were to act on the recommendations today, how quickly could our domestic capacity expand? If we were to act on this, how quickly can we get this up and running?” Mr. Cashman: “With the right policy framework, we could significantly expand production with 18 to 24 months. We're currently running three active production lines; we have two crews on first shift and another crew on second shift. By simply adding new crews, to adding shifts so we can have three shifts per day on each line, we could dramatically increase our production.” Congressman Troy Balderson (OH-12): “ We know that a recent analysis showed that around half of the active pharmaceutical ingredients (APIs) for prescription medications in the U.S come from India and the EU. With around 12 percent being manufactured domestically here in the U.S. from your perspective and with your great experience, how do you believe we can increase the share in a sustainable way?” Dr. Piervincenzi: “I think the first layer is to increase the production of API, [which] will require new facilities and substantial new investments and time. There are shorter term ways to bridge the gap and to create a more secure supply chain, including through friend shoring and other purchasing opportunities. And finally, also considering the potentially even higher vulnerability to the starting materials upstream of the APIs, which may be even more highly concentrated in adversary countries and coming to the U.S. through India and Europe.” Congressman Jay Obernolte: (CA-23): “One of the things [Mr. Cashman] suggested was long-term supply contracts, but if you are someone that has consistent demand for a drug like amoxicillin, and you've experienced a situation where supply is constrained and therefore the market reacts by raising prices up to astronomical levels, you would think that would incentivize you, just from a financial perspective, to diversify your supply chains.”

WASHINGTON, D.C.  – The following op-ed by Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, appeared in Fox News last week. In Case You Missed It: “It’s been almost two weeks since the House of Representatives passed the ‘One, Big, Beautiful Bill’ Act (OBBBA). Yet, we continue to hear constant fearmongering by my Democrat colleagues.  “I’ll remind you that the OBBBA makes tremendous strides in providing further tax cuts for middle-class, working families, promoting American manufacturing and energy dominance, and importantly, protecting the integrity of our healthcare programs to support our most vulnerable Americans.  “It is a top priority of House Republicans to eliminate the waste, fraud and abuse in the programs and safeguard expectant mothers, their children, low-income seniors and especially individuals living with disabilities who are receiving Medicaid coverage. Regrettably, Democrats continue to fuel the falsehood that 13 million individuals will lose healthcare coverage under OBBBA.  “According to the Congressional Budget Office, millions of ineligible individuals are receiving benefits through Medicaid, with 1.6 million people enrolled in two state Medicaid programs at the same time (and getting care paid for in both states), 1.4 million illegal immigrants, and 1.2 million enrollees who no longer qualify for eligibility. CBO also assumes there are 4.8 million able-bodied adults without dependents who would rather lose Medicaid coverage than choose to work or give back to their communities. Continuing to direct scarce resources to these ineligible recipients ultimately takes away from Americans truly in need.  “Through the OBBBA, Republicans are strengthening the Medicaid program by removing ineligible beneficiaries and sustaining the program for our most vulnerable Americans. When states are no longer paying for those who shouldn’t be enrolled in the first place, that frees up money they can invest for those who actually need the care most.  “As chairman of the House Committee on Energy and Commerce, please allow me to tell you the truth: pregnant women, children, seniors, and individuals living with a disability are protected under this legislation.  “During our 26-and-a-half-hour marathon markup, Democrats shared stories using scare-tactics, not facts. The Democrats cited story after story about vulnerable individuals who rely on Medicaid for their daily care – like children and people with disabilities and their families – and the fact is, this bill does not impact them. If anything, we are protecting Medicaid for them.  “Every vulnerable American who needs Medicaid should be protected and have access to care. That’s why House Republicans have thoughtfully curated a bill that realigns incentives in Medicaid for states to care for the most vulnerable over individuals who aren’t eligible for the program, including illegal immigrants.  “While Medicaid is predominantly funded by the federal government, states are in the driver’s seat and contribute at least a third of all Medicaid costs, ultimately determining which individuals are covered, what services they receive, and how much taxpayers pay for their care. Our bill reverses a Biden-Harris policy that prohibited states from removing ineligible individuals from their rolls.  “When top-down mandates from Washington crowd out state decision-making, states lose their ability to focus their efforts on core services for vulnerable populations. Our bill changes this. For example, the commonsense community-engagement requirements, also known as work requirements, require that states ensure that able-bodied adults without dependents are either working a part-time job, participating in educational programs, or volunteering in their community for 80 hours per month in order to receive Medicaid benefits.  “Additionally, the bill repeals oppressive Biden-Harris era mandates that forced states to impose unrealistic staffing requirements for nursing homes that were set to close facilities and severely restrict access to care. The Biden-Harris regulators also prohibited states from following standard procedures to disenroll people who are ineligible for coverage, or even fraudulently enrolled, in Medicaid.  “The rational policies in the House bill that stops coverage for illegal immigrants and allows states to remove deceased and duplicative enrollees, and otherwise ineligible beneficiaries from state Medicaid programs further ensures our federal dollars are serving the population that Medicaid was created to protect.  “We must remember that even with the Energy and Commerce Committee’s title creating savings of over $1 trillion, we still don’t halt the rapid pace at which the Medicaid program is growing.  “While the Committee’s savings help to slow the growth of the program, Medicaid is projected to grow by an estimated 25% by 2034. Over the next decade, spending in the program is expected to increase by over $1 trillion above inflation. Only Washington Democrats would say that increased funding is a cut.  “Every dollar misspent on illegal immigrants and ineligible individuals in the Medicaid program means less money going to our children, our pregnant women and mothers, individuals who are disabled, and seniors.  “It is disappointing that Democrats are prioritizing politics through lies and fearmongering instead of actually helping the most vulnerable Americans. House Republicans make no apologies for our continued fight to strengthen government programs that have since been riddled with waste, fraud, and abuse.”

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Buddy Carter (GA-01), Chairman of the Subcommittee on Health, announced a hearing titled Made in America: Strengthening Domestic Manufacturing and the Health Care Supply Chain .  “We have long been champions of policies that support efforts to onshore U.S.-based manufacturing and bolster our domestic supply chain, while, at the same time, strengthening our national security interests and economic goals,” said Chairmen Guthrie and Carter. “ Reducing America’s reliance on other nations for essential medications and health care products has been a long-standing priority of the Subcommittee on Health, and we look forward to examining the current challenges and opportunities to best incentivize and establish a reliable, safe, resilient, and efficient health care supply chain.”   Subcommittee on Health hearing titled Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain   WHAT: Subcommittee on Health hearing on Strengthening Domestic Manufacturing and the Health Care Supply Chain.  DATE: Wednesday, June 11, 2025  TIME: 10:00 AM ET  LOCATION: 2123 Rayburn House Office Building  This notice is at the direction of the Chairman. The hearing will be open to the public and press and will be livestreamed online at energycommerce.house.gov . If you have any questions concerning this hearing, please contact Annabelle Huffman at Annabelle.Huffman@mail.house.gov . If you have any press-related questions, please contact Katie West at Katie.West@mail.house.gov .   ###

WASHINGTON, D.C. – Yesterday, the House Committee on Energy and Commerce, led by Chairman Brett Guthrie (KY-02), reported six pieces of legislation to the full House of Representatives. Chairman Guthrie issued the following statement after the conclusion of the markup. “This markup was another important opportunity for our committee to advance legislation to support the most vulnerable Americans ,” said Chairman Guthrie. “All of these bipartisan bills reflect our commitment to improving Americans’ health and strengthening our health care system. Thank you to all of the sponsors for their hard work to champion this vital legislation.”  Legislative Vote Summary: H.R. 2483 , SUPPORT for Patients and Communities Reauthorization Act of 2025, was reported to the full House by a roll call vote of 36 yeas – 13 nays. H.R. 1520 , Charlotte Woodward Organ Transplant Discrimination Prevention Act, was reported to the full House by a roll call vote of 46 yeas – 1 nay. H.R. 2319 , Women and Lung Cancer Research and Preventive Services Act of 2025, was reported to the full House by voice vote. H.R. 1669 , To amend the Public Health Service Act to reauthorize the Stop, Observe, Ask, and Respond to Health and Wellness Training Program, was reported to the full House by voice vote. H.R. 1082 , Shandra Eisenga Human Cell and Tissue Product Safety Act, was reported to the full House by voice vote. H.R. 2484 , Seniors’ Access to Critical Medications Act, was reported to the full House by a roll call vote of 38 yeas – 7 nays. Watch the full markup here . Below are key excerpts from yesterday’s markup: Congressman Brett Guthrie (KY-02) on the SUPPORT Act: “For far too long, Americans have witnessed the unprecedented rise in drug overdoses and substance use disorders, creating an imminent need for prevention, treatment and recovery services. The SUPPORT for Patients and Communities Reauthorization Act is a long standing priority for me and all the members of this committee, and this bill would reauthorize essential public health programs focused on prevention, treatment, and recovery for patients with substance use disorder.” Congresswoman Kat Cammack (FL-03) on the Charlotte Woodward Organ Transplant Discrimination Prevention Act: “This legislation is named in honor of Charlotte Woodward, a remarkable young woman with Down syndrome, who received a life-saving heart transplant more than 12 years ago. Charlotte is here with us today, and one day, she's going to be a member of Congress. That's what I'm putting my money on, but her presence here today is a powerful reminder that every life has value and potential, regardless of disability.” Congresswoman Diana Harshbarger (TN-01) on Seniors’ Access to Critical Medications Act: “ This legislation would provide continuation of pre-pandemic era flexibilities for specialty physicians and other healthcare providers to be able to deliver oral medications to patients by mail delivery or courier, or it would allow a designated caregiver or family member to pick up these medications instead for the patients. It's critically important for the well-being of cancer patients and others with serious diseases who are too sick to pick up their medications in person who live in rural areas distant from their physicians or who simply do not have transportation.” ###

WASHINGTON, D.C.  –  Today, the House Committee on Energy and Commerce, led by Chairman Brett Guthrie (KY-02), will mark up 26 bills, including H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025. This bipartisan legislation, which is co-led by Chairman Guthrie and Congresswoman Brittany Pettersen (CO-07), has received widespread support from over 160 vital substance use disorder treatment and recovery organizations. Here’s what they’re saying: “The state of behavioral health in America remains a national crisis, with millions of people across the nation experiencing an SUD and 1 in 5 Americans experiencing an MH condition each year,” said Debbie Witchey, MHA, President and CEO of Association for Behavioral Health and Wellness (ABHW). “The SUPPORT Act is critical to effectively addressing SUDs and co-occurring MH conditions. Its policies and provisions will continue to embrace prevention, treatment, and a pathway to recovery.” “Last month, the Centers for Disease Control and Prevention reported a nearly 24% decline in drug overdose deaths from September 2023 through September 2024. The number of overdose deaths during this 12-month period was the lowest since June 2020,” said Advocates for Opioid Addiction Treatment (AOAT). “Without question, the bipartisan SUPPORT Act of 2018, which expanded access to treatment and began addressing treatment workforce shortages played a critical role in reversing the tragic and deadly overdose trend and saving lives.”  “Overdose rates are beginning to drop slightly, and we firmly believe that our investment in recovery support services is a major reason why. The SUPPORT Act gave rise to the Building Communities of Recovery Program, which seeks to mobilize and connect a broad array of community-based resources for persons with substance use disorders (SUD) and co-occurring substance use and mental disorders (COD),” said Patty McCarthy, CEO of Faces & Voices of Recovery. “You have our full-throated support for the passage of this legislation, and we look forward to your continued commitment to the advancement of SUD treatment and recovery.”  Background:  H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025 reauthorizes key public health programs focused on prevention, treatment, and recovery for patients with substance use disorder that were established in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, which was signed into law in 2018. Full list of supporting organizations:  A Stepping Stone to Success Active Minds ADA Women's Center Addiction Policy Forum Addiction Professionals of North Carolina Advocates for Opioid Addiction Treatment (AOAT) Akin American Association for the Treatment of Opioid Dependence (AATOD) American Association of Addiction Nursing American College of Emergency Physicians (ACEP) American Foundation for Suicide Prevention American Jail Association American Podiatric Medical Association (APMA) Association for Behavioral Health and Wellness (ABHW) Association of Prosecuting Attorneys Barbie Girl Ink LLC Behavioral Health Foundation Beyond Addiction Boone County Drug Prevention Coalition Brain First Family Center Bridging Hope, Inc. Brightpoint Bring Light Save Life C.A.R.E CADCA California Consortium of Addiction Programs & Professionals Centerstone Center for Adolescent Behavioral Health Research, Boston Children's Hospital Chesapeake Integrated Behavioral Healthcare Children’s Hope Alliance Command Destinations Community in Connection Couve Collective Crossroads To Intervention, Inc Crosswinds Recovery Dayspring Foundation DePaul’s NCADD-RA Devin J. Norring Foundation Entertainment Industries Council, Inc. (EIC) Eating Disorders Coalition for Research, Policy, & Action (EDC) Faces & Voices of Recovery First Step Counseling & Educational Services Families Forward Michigan FASCETS Center for Neurodiversity FASD Changemakers FASD Collaborative Project FASD Network of Northern California FASD Network of Southern California FASD Strong FASD United FASDNow! Florissa Pediatric Development Center FLOW Counseling & Guidance, Pllc Formed Families Forward Foster Family Alliance of North Carolina Freund & Associates, LLC Functional Link Occupational Therapy Grant a Gift Autism Foundation Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson Hawaii FASD Action Group Healthcare Leadership Council Heart & Soul Speech Hopewell HOR Community Solutions, LLC Huntington, WV QRT (Quick Response Team) Hurley House IC&RC Illuminate Colorado InforMATION, LLC Inseparable Institute for Behavior and Health, Inc. International Certification and Reciprocity Consortium (IC&RC) Iowa Harm Reduction Coalition Jenks Forensic Addictions Services JLM Research and Evaluation Kansas FASD Support Network, Inc Kasper’s FASD Life Coaching & Training Kentucky Alliance of Recovery Services Kohnlinq, Inc. Latino Ministers of New Jersey For Justice Liberation Programs Long Island Recovery Association Maddie Wright Foundation Madison County Recovery Allies Magical Manners Club for Boys & Girls Maryland Legislative Coalition Meadows Behavioral Healthcare Mental Health America Mental Health Colorado Mental Health Liaison Group (MHLG) Merakey Michigan Coalition for Fetal Alcohol Resources Education and Support Mighty Crow Milford Prevention Council Mississippi Society of Addiction Medicine Missouri Works Initiative Montgomery County Federation of Families for Children's Mental Health, Inc. NAMI Southeastern Arizona National Alliance for Comprehensive Addiction Treatment Solutions (NACATS) National Alliance on Mental Illness (NAMI) National Alliance on Mental Illness, Southeastern AZ National Association for Behavioral Healthcare (NABH) National Association for Children of Addiction National Association of Addiction Treatment Providers National Behavioral Health Association of Providers National Council for Mental Wellbeing National Council on Problem Gambling (NCPG) National Disability Rights Network (NDRN) National District Attorneys Association NCFASD Informed, Inc. Neuro.behavioral.connections New Jersey Association of Mental Health and Addiction Agencies, Inc. New Jersey Center for Empowerment and Community Development New York State Council for Community Behavioral Healthcare No More ODs, Inc. Objective Recovery, Inc. Ohio Mental Health and Addiction Services Oregon Council for Behavioral Health PACID: Parent Advocates for Adult Children with IDD Power Forward, Inc. Prevention Action Alliance RASE Project ReBuilding Bridges Consulting, LLC Recovery Revolutionists Rockland Recovery Homes, Inc. Sacred Hearts Psychiatry and Addiction Medicine Sage Advice Therapy LLC Salisbury Elks #699 SC FASD COLLABORATIVE SEIU Local 500 Serenity Now - Nar-Anon Chapter Shatterproof Skyland Trail South Florida Wellness Network St. Joseph's Behavioral Health Center Supporting Community in Recovery Fund/Yakima Valley Community Foundation TASC, Inc. (Treatment Alternatives for Safe Communities) Teton County Health Department - Prevention Texas FASD Network The BROCK Foundation The Florida Center The Florida Center for Early Childhood The Kennedy Forum The Ohio Council of Behavioral Health and Family Services Providers The Papillion Center Kentucky The Sanctuary Foster Care Services Thrive Family Recovery Resources Treatment Communities of America Tyler's Redemption Place University of Washington UT Tyler School of Medicine Valley Court Diversion Programs Village Collaboration Station, PC Wake Up Nevada LLC WeKonnect LLC Westcare White Flint Family Pharmacy WV Drug Intervention Institute Wyoming County Special Needs Association 101 Ways 21-14 CAF Click here to for full bill text of H.R. 2483. ###

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter, Chairman of the Subcommittee on Health, issued the following statement after Dr. Mehmet Oz was confirmed by the Senate to serve as Administrator of the Centers for Medicare and Medicaid Services (CMS). “CMS plays an integral role in ensuring Americans can access health care, particularly for seniors, pregnant women, children, and individuals with disabilities,” said Chairmen Guthrie and Carter . “Dr. Oz is an accomplished physician, an innovator, and a world-class communicator, who will help modernize the agency by utilizing new cutting-edge technology that empowers health care providers to better serve the American people. We look forward to partnering with him to improve health outcomes for Americans.” ###

WASHINGTON, D.C. – Yesterday, Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, led a hearing titled Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs .  “Over-the-counter (OTC) medications help Americans live longer, healthier, and more comfortable lives. This hearing was critical to understanding the vital role that safe, reliable, and affordable OTC medications play in our nation’s overall health,” said Chairman Carter. “I look forward to working in a bipartisan manner to reauthorize the Over-the-Counter Monograph Drug User Fee Program so that we can continue to support FDA’s work to bring pharmaceutical manufacturing back to America and increase patient access to OTC medications.”   Watch the full hearing here .  Below are key excerpts from yesterday’s hearing : Congressman John Joyce (PA-13): “The United States is home to world leading medical innovation. In fact, I often talk about innovation being the cornerstone of American medicine, being the cornerstone of how I practice medicine. Unfortunately, the FDA’s inaction has prevented this innovation, allowing the rest of the world to access new active sunscreen ingredients that are unavailable to Americans. Can you expand upon some of the barriers that are hindering the great innovation by not utilizing the information that our friends and allies have access to?” Mr. D’Ruiz: “People don’t die from using sunscreen. They die from not using sunscreen, number one. And I think there is a large body of evidence worldwide indicating that the news of young sunscreen filters, which have been developed over the last 10 years, are much more efficient – you use less, there is less exposure, and they are much more effective in reducing the harmful effects of both UVA and B. And three, they are more sustainable in terms of environmental impact.” Congresswoman Kat Cammack (FL-13): “You have companies that are already doing things the right way. We don’t want to punish them by putting additional burdens on them to try to capture those companies that are not in compliance. How can we handle that?” Mr. Menzel: “I think that it’s an incredibly important point that we don’t need more regulation as it relates to this, so there needs to be predictability. The OMUFA program allows predictability. The monograph program allows predictability, allows for innovation, allows for speed.”   Congressman Bob Latta (OH-05): “The Over-the-Counter Monograph Drug User Fee Program (OMUFA) at the Food and Drug Administration has produced more than 100,000 safe and effective over-the-counter drugs, giving consumers access to manage their own care in a safe and affordable manner. The OMUFA program has also reduced the number of visits consumers need to make to a doctor to obtain a prescription for a simple treatment, reducing the burden on our health care systems. The OMUFA program has also increased access and choice for consumers. Could you provide examples of how this is beneficial to the public within the United States?” Mr. Menzel: “Yeah , absolutely, I think, in terms of the benefit to the US consumer, one of the items that I think continually needs to be reinforced is for every $1 spent in this space on over-the-counter medicines, it saves the United States health care system $7 in terms of doctor visit cost savings. Pharmaceutical alternatives to pharmaceutical cost savings, the other thing that system does is it allows for a shrinking of these healthcare deserts, where access would be limited, not just in rural areas, but also urban areas that are limited by access to health care.” ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (GA-01), Chairman of the Subcommittee on Health, issued the following statement regarding Department of Health and Human Services (HHS) Secretary Kennedy’s restructuring announcement in accordance with President Trump’s Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” “For decades, HHS and its sub-agencies have grown significantly, creating redundancies and—in some cases—conflicting objectives. It is critical that the department is in a position to accomplish its core and essential mission to support all Americans,”  said Chairmen Guthrie and Carter . “We look forward to working with Secretary Kennedy to protect patients, support innovations, and improve the health and wellbeing of the American people.” ###

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement after Dr. Marty Makary, MD, MPH was confirmed by the U.S. Senate to serve as Commissioner of Food and Drugs of the Food and Drug Administration (FDA).  “Americans—and, in many cases, the world—depend on the FDA’s gold standard of determining the safety and effectiveness of medicines and medical products for patients,”  said Chairman Guthrie.  “I’m confident that Dr. Makary’s medical and research experience, coupled with his thoughtfulness, will help strengthen the FDA. I congratulate him on his confirmation and look forward to working together to better serve the American people.” ###